REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,718,767 | -54.8% | 4,160,311 | -0.2% | 0.35% | -33.5% |
| Q2 2023 | $105,488,081 | -21.4% | 4,167,842 | 0.0% | 0.53% | -39.0% |
| Q1 2023 | $134,246,191 | +50.0% | 4,167,842 | -14.0% | 0.87% | +22.3% |
| Q4 2022 | $89,505,765 | -25.7% | 4,848,633 | +8.7% | 0.71% | -7.2% |
| Q3 2022 | $120,467,000 | +179.6% | 4,461,747 | +43.1% | 0.77% | +203.6% |
| Q2 2022 | $43,078,000 | -10.1% | 3,117,052 | +26.9% | 0.25% | +17.1% |
| Q1 2022 | $47,902,000 | +29.9% | 2,456,497 | +8.7% | 0.22% | +56.5% |
| Q4 2021 | $36,878,000 | -24.1% | 2,259,700 | +29.6% | 0.14% | -30.3% |
| Q3 2021 | $48,560,000 | +41.9% | 1,742,997 | +50.9% | 0.20% | +32.9% |
| Q2 2021 | $34,226,000 | +6.0% | 1,154,734 | 0.0% | 0.15% | -25.5% |
| Q1 2021 | $32,275,000 | -1.4% | 1,154,734 | 0.0% | 0.20% | +1.0% |
| Q4 2020 | $32,725,000 | – | 1,154,734 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |